CRBP stock

Corbus Pharmaceuticals Holding (CRBP) financials · $102.3M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Corbus Pharmaceuticals Holding (CRBP) $102.3M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$85.3M-$48.7M
Net Income-$78.5M-$40.2M
EPS (Diluted)-$5.90-$3.68
Cached annual balance sheet
LineFY2025FY2024
Total Assets$168.2M$155.9M
Current Assets$167.0M$153.0M
Cash & Equivalents$28.5M$17.2M
PP&E$159.0K$385.0K
Total Liabilities$20.7M$13.5M
Current Liabilities$20.7M$11.8M
Shareholders' Equity$147.5M$142.4M
Retained Earnings-$555.4M-$476.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$64.5M-$41.8M
CapEx$7.00KN/A
Investing Cash Flow-$1.64M-$121.3M
Financing Cash Flow$77.4M$166.6M
Net Change in Cash$11.3M$3.47M
Free Cash Flow-$64.5M-$41.8M
These statements as JSON? API free 100/day

FAQ

What is CRBP P/E and revenue?

Corbus Pharmaceuticals Holding (CRBP) $102.3M cap.

What is CRBP revenue?

CRBP income-statement cache has no revenue figure yet.

Is CRBP profitable?

Corbus Pharmaceuticals Holding last cached net income is -$78.5M (FY2025).

What are CRBP total assets?

Corbus Pharmaceuticals Holding last cached total assets are $168.2M (FY2025).

What is CRBP free cash flow?

Corbus Pharmaceuticals Holding last cached free cash flow is -$64.5M (FY2025).

Not investment advice. Cached statements, not a live tape.